150 related articles for article (PubMed ID: 32003141)
1. The cost-effectiveness of progesterone in preventing miscarriages in women with early pregnancy bleeding: an economic evaluation based on the PRISM trial.
Okeke Ogwulu CB; Goranitis I; Devall AJ; Cheed V; Gallos ID; Middleton LJ; Harb HM; Williams HM; Eapen A; Daniels JP; Ahmed A; Bender-Atik R; Bhatia K; Bottomley C; Brewin J; Choudhary M; Deb S; Duncan WC; Ewer AK; Hinshaw K; Holland T; Izzat F; Johns J; Lumsden M; Manda P; Norman JE; Nunes N; Overton CE; Kriedt K; Quenby S; Rao S; Ross J; Shahid A; Underwood M; Vaithilingham N; Watkins L; Wykes C; Horne AW; Jurkovic D; Coomarasamy A; Roberts TE
BJOG; 2020 May; 127(6):757-767. PubMed ID: 32003141
[TBL] [Abstract][Full Text] [Related]
2. Progesterone to prevent miscarriage in women with early pregnancy bleeding: the PRISM RCT.
Coomarasamy A; Harb HM; Devall AJ; Cheed V; Roberts TE; Goranitis I; Ogwulu CB; Williams HM; Gallos ID; Eapen A; Daniels JP; Ahmed A; Bender-Atik R; Bhatia K; Bottomley C; Brewin J; Choudhary M; Crosfill F; Deb S; Duncan WC; Ewer A; Hinshaw K; Holland T; Izzat F; Johns J; Lumsden MA; Manda P; Norman JE; Nunes N; Overton CE; Kriedt K; Quenby S; Rao S; Ross J; Shahid A; Underwood M; Vaithilingham N; Watkins L; Wykes C; Horne AW; Jurkovic D; Middleton LJ
Health Technol Assess; 2020 Jun; 24(33):1-70. PubMed ID: 32609084
[TBL] [Abstract][Full Text] [Related]
3. PROMISE: first-trimester progesterone therapy in women with a history of unexplained recurrent miscarriages - a randomised, double-blind, placebo-controlled, international multicentre trial and economic evaluation.
Coomarasamy A; Williams H; Truchanowicz E; Seed PT; Small R; Quenby S; Gupta P; Dawood F; Koot YE; Atik RB; Bloemenkamp KW; Brady R; Briley A; Cavallaro R; Cheong YC; Chu J; Eapen A; Essex H; Ewies A; Hoek A; Kaaijk EM; Koks CA; Li TC; MacLean M; Mol BW; Moore J; Parrott S; Ross JA; Sharpe L; Stewart J; Trépel D; Vaithilingam N; Farquharson RG; Kilby MD; Khalaf Y; Goddijn M; Regan L; Rai R
Health Technol Assess; 2016 May; 20(41):1-92. PubMed ID: 27225013
[TBL] [Abstract][Full Text] [Related]
4. Micronized vaginal progesterone to prevent miscarriage: a critical evaluation of randomized evidence.
Coomarasamy A; Devall AJ; Brosens JJ; Quenby S; Stephenson MD; Sierra S; Christiansen OB; Small R; Brewin J; Roberts TE; Dhillon-Smith R; Harb H; Noordali H; Papadopoulou A; Eapen A; Prior M; Di Renzo GC; Hinshaw K; Mol BW; Lumsden MA; Khalaf Y; Shennan A; Goddijn M; van Wely M; Al-Memar M; Bennett P; Bourne T; Rai R; Regan L; Gallos ID
Am J Obstet Gynecol; 2020 Aug; 223(2):167-176. PubMed ID: 32008730
[TBL] [Abstract][Full Text] [Related]
5. Progesterone for women with threatened miscarriage (STOP trial): a placebo-controlled randomized clinical trial.
McLindon LA; James G; Beckmann MM; Bertolone J; Mahomed K; Vane M; Baker T; Gleed M; Grey S; Tettamanzi L; Mol BWJ; Li W
Hum Reprod; 2023 Apr; 38(4):560-568. PubMed ID: 36806843
[TBL] [Abstract][Full Text] [Related]
6. A Randomized Trial of Progesterone in Women with Bleeding in Early Pregnancy.
Coomarasamy A; Devall AJ; Cheed V; Harb H; Middleton LJ; Gallos ID; Williams H; Eapen AK; Roberts T; Ogwulu CC; Goranitis I; Daniels JP; Ahmed A; Bender-Atik R; Bhatia K; Bottomley C; Brewin J; Choudhary M; Crosfill F; Deb S; Duncan WC; Ewer A; Hinshaw K; Holland T; Izzat F; Johns J; Kriedt K; Lumsden MA; Manda P; Norman JE; Nunes N; Overton CE; Quenby S; Rao S; Ross J; Shahid A; Underwood M; Vaithilingam N; Watkins L; Wykes C; Horne A; Jurkovic D
N Engl J Med; 2019 May; 380(19):1815-1824. PubMed ID: 31067371
[TBL] [Abstract][Full Text] [Related]
7. Progestogen for preventing miscarriage.
Haas DM; Ramsey PS
Cochrane Database Syst Rev; 2013 Oct; (10):CD003511. PubMed ID: 24173668
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of mifepristone and misoprostol versus misoprostol alone for the management of missed miscarriage: an economic evaluation based on the MifeMiso trial.
Okeke Ogwulu CB; Williams EV; Chu JJ; Devall AJ; Beeson LE; Hardy P; Cheed V; Yongzhong S; Jones LL; La Fontaine Papadopoulos JH; Bender-Atik R; Brewin J; Hinshaw K; Choudhary M; Ahmed A; Naftalin J; Nunes N; Oliver A; Izzat F; Bhatia K; Hassan I; Jeve Y; Hamilton J; Debs S; Bottomley C; Ross J; Watkins L; Underwood M; Cheong Y; Kumar CS; Gupta P; Small R; Pringle S; Hodge FS; Shahid A; Horne AW; Quenby S; Gallos ID; Coomarasamy A; Roberts TE
BJOG; 2021 Aug; 128(9):1534-1545. PubMed ID: 33969614
[TBL] [Abstract][Full Text] [Related]
9. Progestogen for preventing miscarriage.
Oates-Whitehead RM; Haas DM; Carrier JA
Cochrane Database Syst Rev; 2003; (4):CD003511. PubMed ID: 14583982
[TBL] [Abstract][Full Text] [Related]
10. Effect of progestogen for women with threatened miscarriage: a systematic review and meta-analysis.
Li L; Zhang Y; Tan H; Bai Y; Fang F; Faramand A; Chong W; Hai Y
BJOG; 2020 Aug; 127(9):1055-1063. PubMed ID: 32324957
[TBL] [Abstract][Full Text] [Related]
11. Progestogen for preventing miscarriage.
Haas DM; Ramsey PS
Cochrane Database Syst Rev; 2008 Apr; (2):CD003511. PubMed ID: 18425891
[TBL] [Abstract][Full Text] [Related]
12. Study of progesterone for the prevention of preterm birth in twins (STOPPIT): findings from a trial-based cost-effectiveness analysis.
Eddama O; Petrou S; Regier D; Norrie J; MacLennan G; Mackenzie F; Norman JE
Int J Technol Assess Health Care; 2010 Apr; 26(2):141-8. PubMed ID: 20392316
[TBL] [Abstract][Full Text] [Related]
13. Cost and cost effectiveness of vaginal progesterone gel in reducing preterm birth: an economic analysis of the PREGNANT trial.
Pizzi LT; Seligman NS; Baxter JK; Jutkowitz E; Berghella V
Pharmacoeconomics; 2014 May; 32(5):467-78. PubMed ID: 24715602
[TBL] [Abstract][Full Text] [Related]
14. Vaginal progesterone prophylaxis for preterm birth (the OPPTIMUM study): a multicentre, randomised, double-blind trial.
Norman JE; Marlow N; Messow CM; Shennan A; Bennett PR; Thornton S; Robson SC; McConnachie A; Petrou S; Sebire NJ; Lavender T; Whyte S; Norrie J;
Lancet; 2016 May; 387(10033):2106-2116. PubMed ID: 26921136
[TBL] [Abstract][Full Text] [Related]
15. Luteal phase support for assisted reproduction cycles.
van der Linden M; Buckingham K; Farquhar C; Kremer JA; Metwally M
Cochrane Database Syst Rev; 2011 Oct; (10):CD009154. PubMed ID: 21975790
[TBL] [Abstract][Full Text] [Related]
16. A Randomized Trial of Progesterone in Women with Recurrent Miscarriages.
Coomarasamy A; Williams H; Truchanowicz E; Seed PT; Small R; Quenby S; Gupta P; Dawood F; Koot YE; Bender Atik R; Bloemenkamp KW; Brady R; Briley AL; Cavallaro R; Cheong YC; Chu JJ; Eapen A; Ewies A; Hoek A; Kaaijk EM; Koks CA; Li TC; MacLean M; Mol BW; Moore J; Ross JA; Sharpe L; Stewart J; Vaithilingam N; Farquharson RG; Kilby MD; Khalaf Y; Goddijn M; Regan L; Rai R
N Engl J Med; 2015 Nov; 373(22):2141-8. PubMed ID: 26605928
[TBL] [Abstract][Full Text] [Related]
17. Oral dydrogesterone for prevention of miscarriage in threatened miscarriage: a randomized, double-blind, placebo-controlled trial.
Kuptarak A; Phupong V
J Matern Fetal Neonatal Med; 2024 Dec; 37(1):2333929. PubMed ID: 38570191
[TBL] [Abstract][Full Text] [Related]
18. First trimester threatened miscarriage treatment with human chorionic gonadotrophins: a randomised controlled trial.
Qureshi NS; Edi-Osagie EC; Ogbo V; Ray S; Hopkins RE
BJOG; 2005 Nov; 112(11):1536-41. PubMed ID: 16225575
[TBL] [Abstract][Full Text] [Related]
19. [Effectiveness of progesterone in pregnancy complications].
van der Hoorn MP; Lashley EELO
Ned Tijdschr Geneeskd; 2019 Oct; 163():. PubMed ID: 31682091
[TBL] [Abstract][Full Text] [Related]
20. Antibiotic prophylaxis in the surgical management of miscarriage in low-income countries: a cost-effectiveness analysis of the AIMS trial.
Goranitis I; Lissauer DM; Coomarasamy A; Wilson A; Daniels J; Middleton L; Bishop J; Hewitt CA; Weeks AD; Mhango C; Mataya R; Ahmed I; Oladapo OT; Zamora J; Roberts TE
Lancet Glob Health; 2019 Sep; 7(9):e1280-e1286. PubMed ID: 31402008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
